Heart base tumor radiation
therapy for dogs
in Florida.

When surgery is not possible,
radiation therapy is the treatment.

Chemodectomas of the heart base are intimately adherent to the aorta, pulmonary artery, and the heart itself. Surgical resection — already technically demanding — carries prohibitive cardiovascular risk in nearly all cases. Radiation therapy is the only meaningful local treatment option, and it works: multiple case series document tumor stabilization and meaningful survival extension.

Chemodectomas are slow-growing tumors that arise from chemoreceptor cells in the aortic body near the heart base. They grow locally and rarely metastasize — which means a dog with a chemodectoma has no systemic cancer burden, just a local problem in a difficult location. This is a situation where radiation therapy, delivered with sufficient precision, can convert a fatal diagnosis into a manageable chronic condition.

Pericardial effusion — the most common acute presentation

Many dogs with heart base tumors present first with pericardial effusion — fluid accumulation around the heart that impairs cardiac filling. This is managed acutely with pericardiocentesis (drainage). Once the effusion is controlled, CT imaging and cardiac evaluation guide radiation planning. Radiation can reduce tumor volume and decrease recurrent effusion — sometimes eliminating the need for repeated pericardiocentesis.

Why precision matters most here

The heart base is surrounded by the most radiation-sensitive structures in the body — the heart, aorta, pulmonary artery, lungs, and esophagus. Treatment planning requires strict dose constraints on all adjacent organs while delivering adequate dose to the tumor volume. This is exactly the kind of case where stereotactic precision (SRS/SRT) demonstrates its greatest advantage over conventional techniques.